Dendrimer-driven neurotrophin expression differs in temporal patterns between rodent and human stem cells

Molecular Pharmaceutics

Volumn 9, Issue 5, 2012, Pages 1521-1528

  Shakhbazau, Antos ^a,b   Shcharbin, Dzmitry ^c   Seviaryn, Ihar ^d   Goncharova, Natalya ^d   Kosmacheva, Svetlana ^d   Potapnev, Mihail ^d   Bryszewska, Maria ^e   Kumar, Ranjan ^a,b   Biernaskie, Jeffrey ^a,b   Midha, Rajiv ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c INSTITUTE OF PHOTOBIOLOGY   (Belarus)

^d Republic Centre for Hematology and Transfusiology   (Belarus)

^e UNIVERSITY OF LODZ   (Poland)

Author keywords

BDNF; mesenchymal stem cells; NT 3; PAMAM dendrimers; skin precursor derived Schwann cells; transfection

Indexed keywords

NEUROTROPHIN 3; POLYAMIDOAMINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL; TIME PERCEPTION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; DENDRIMERS; HUMANS; MESENCHYMAL STROMAL CELLS; NERVE GROWTH FACTORS; NEUROTROPHIN 3; OSTEOGENESIS; PLASMIDS; TRANSFECTION;

EID: 84860761320     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300041k     Document Type: Article

References (65)

1. Burdick, J. A.; Vunjak-Novakovic, G. Engineered microenvironments for controlled stem cell differentiation Tissue Eng., Part A 2009, 15 (2) 205-219
2. Pandita, D.; Santos, J. L.; Rodrigues, J.; Pego, A. P.; Granja, P. L.; Tomas, H. Gene delivery into mesenchymal stem cells: a biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimers Biomacromolecules 2011, 12 (2) 472-481
3. Toma, J. G.; Akhavan, M.; Fernandes, K. J.; Barnabe-Heider, F.; Sadikot, A.; Kaplan, D. R.; Miller, F. D. Isolation of multipotent adult stem cells from the dermis of mammalian skin Nat. Cell Biol. 2001, 3 (9) 778-784
4. Bianchi, B. R.; Zhang, X. F.; Reilly, R. M.; Kym, P. R.; Yao, B. B.; Chen, J. Species comparison and pharmacological characterization of human, monkey, rat and mouse TRPA1 channels J. Pharmacol. Exp. Ther. 2012, 341, 360-368
5. Harries, L. W.; Brown, J. E.; Gloyn, A. L. Species-specific differences in the expression of the HNF1A, HNF1B and HNF4A genes PLoS One 2009, 4 (11) e7855
6. Holden, P. R.; Tugwood, J. D. Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences J. Mol. Endocrinol. 1999, 22 (1) 1-8
7. Hu, Y.; Leaver, S. G.; Plant, G. W.; Hendriks, W. T.; Niclou, S. P.; Verhaagen, J.; Harvey, A. R.; Cui, Q. Lentiviral-mediated transfer of CNTF to schwann cells within reconstructed peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal regeneration Mol. Ther. 2005, 11 (6) 906-915
8. Nakahara, Y.; Gage, F. H.; Tuszynski, M. H. Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord Cell Transplant. 1996, 5 (2) 191-204
9. Weidner, N.; Blesch, A.; Grill, R. J.; Tuszynski, M. H. Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1 J. Comp. Neurol. 1999, 413 (4) 495-506
10. Li, Q.; Ping, P.; Jiang, H.; Liu, K. Nerve conduit filled with GDNF gene-modified Schwann cells enhances regeneration of the peripheral nerve Microsurgery 2006, 26 (2) 116-121
11. Brushart, T. M. Nerve Repair; Oxford University Press: New York, 2011.
12. Simpson, P. J.; Wang, E.; Moon, C.; Matarazzo, V.; Cohen, D. R.; Liebl, D. J.; Ronnett, G. V. Neurotrophin-3 signaling maintains maturational homeostasis between neuronal populations in the olfactory epithelium Mol. Cell Neurosci. 2003, 24 (4) 858-874
13. Spencer, T. K.; Mellado, W.; Filbin, M. T. BDNF activates CaMKIV and PKA in parallel to block MAG-mediated inhibition of neurite outgrowth Mol. Cell Neurosci. 2008, 38 (1) 110-116
14. Caldeira, M. V.; Melo, C. V.; Pereira, D. B.; Carvalho, R. F.; Carvalho, A. L.; Duarte, C. B. BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons Mol. Cell Neurosci. 2007, 35 (2) 208-219
15. Ramos, B.; Valin, A.; Sun, X.; Gill, G. Sp4-dependent repression of neurotrophin-3 limits dendritic branching Mol. Cell Neurosci. 2009, 42 (2) 152-159
16. Tannemaat, M. R.; Boer, G. J.; Eggers, R.; Malessy, M. J.; Verhaagen, J. From microsurgery to nanosurgery: how viral vectors may help repair the peripheral nerve Prog. Brain Res. 2009, 175, 173-186
17. Tuszynski, M. H.; Murai, K.; Blesch, A.; Grill, R.; Miller, I. Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord Cell Transplant. 1997, 6 (3) 361-368
18. Eggers, R.; Hendriks, W. T.; Tannemaat, M. R.; van Heerikhuize, J. J.; Pool, C. W.; Carlstedt, T. P.; Zaldumbide, A.; Hoeben, R. C.; Boer, G. J.; Verhaagen, J. Neuroregenerative effects of lentiviral vector-mediated GDNF expression in reimplanted ventral roots Mol. Cell Neurosci. 2008, 39 (1) 105-117
19. Georgievska, B.; Kirik, D.; Bjorklund, A. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer Exp. Neurol. 2002, 177 (2) 461-474
20. Rosenblad, C.; Georgievska, B.; Kirik, D. Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system Eur. J. Neurosci. 2003, 17 (2) 260-270
21. Tannemaat, M. R.; Eggers, R.; Hendriks, W. T.; de Ruiter, G. C.; van Heerikhuize, J. J.; Pool, C. W.; Malessy, M. J.; Boer, G. J.; Verhaagen, J. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve Eur. J. Neurosci. 2008, 28 (8) 1467-1479
22. Winkler, C.; Georgievska, B.; Carlsson, T.; Lacar, B.; Kirik, D. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats Neuroscience 2006, 141 (1) 521-531
23. Blits, B.; Carlstedt, T. P.; Ruitenberg, M. J.; de, W. F.; Hermens, W. T.; Dijkhuizen, P. A.; Claasens, J. W.; Eggers, R.; van der Sluis, R.; Tenenbaum, L.; Boer, G. J.; Verhaagen, J. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor Exp. Neurol. 2004, 189 (2) 303-316
24. Gupta, U.; Agashe, H. B.; Asthana, A.; Jain, N. K. A review of in vitro-in vivo investigations on dendrimers: the novel nanoscopic drug carriers Nanomedicine 2006, 2 (2) 66-73
25. Li, S.; Huang, L. Nonviral gene therapy: promises and challenges Gene Ther. 2000, 7 (1) 31-34
26. Xu, Q.; Wang, C. H.; Pack, D. W. Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers Curr. Pharm. Des. 2010, 16 (21) 2350-2368
27. Thomsen, L. B.; Larsen, A. B.; Lichota, J.; Moos, T. Nanoparticle-derived non-viral genetic transfection at the blood-brain barrier to enable neuronal growth factor delivery by secretion from brain endothelium Curr. Med. Chem. 2011, 18 (22) 3330-3334
28. Jafari, M.; Soltani, M.; Naahidi, S.; Karunaratne, D. N.; Chen, P. Nonviral approach for targeted nucleic Acid delivery Curr. Med. Chem. 2012, 19 (2) 197-208
29. Shcharbin, D.; Pedziwiatr, E.; Blasiak, J.; Bryszewska, M. How to study dendriplexes II: Transfection and cytotoxicity J. Controlled Release 2010, 141 (2) 110-127
30. Tomalia, D. A. Dendrimer research Science 1991, 252 (5010) 1231
31. Shakhbazau, A.; Isayenka, I.; Kartel, N.; Goncharova, N.; Seviaryn, I.; Kosmacheva, S.; Potapnev, M.; Shcharbin, D.; Bryszewska, M. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity Int. J. Pharm. 2010, 383 (1-2) 228-235
32. Biernaskie, J. A.; McKenzie, I. A.; Toma, J. G.; Miller, F. D. Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny Nat. Prot. 2006, 1 (6) 2803-2812
33. Shakhbazau, A.; Shcharbin, D.; Seviaryn, I.; Goncharova, N.; Kosmacheva, S.; Potapnev, M.; Gabara, B.; Ionov, M.; Bryszewska, M. Use of polyamidoamine dendrimers to engineer BDNF-producing human mesenchymal stem cells Mol. Biol. Rep. 2010, 37 (4) 2003-2008
34. Keilhoff, G.; Goihl, A.; Langnase, K.; Fansa, H.; Wolf, G. Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells Eur. J. Cell Biol. 2006, 85 (1) 11-24
35. Azizi, S. A.; Stokes, D.; Augelli, B. J.; DiGirolamo, C.; Prockop, D. J. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - similarities to astrocyte grafts Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (7) 3908-3913
36. Walsh, S.; Biernaskie, J.; Kemp, S. W.; Midha, R. Supplementation of acellular nerve grafts with skin derived precursor cells promotes peripheral nerve regeneration Neuroscience 2009, 164 (3) 1097-1107
37. Lee, R. H.; Kim, B.; Choi, I.; Kim, H.; Choi, H. S.; Suh, K.; Bae, Y. C.; Jung, J. S. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue Cell Physiol. Biochem. 2004, 14 (4-6) 311-324
38. Kohyama, J.; Abe, H.; Shimazaki, T.; Koizumi, A.; Nakashima, K.; Gojo, S.; Taga, T.; Okano, H.; Hata, J.; Umezawa, A. Brain from bone: efficient "meta-differentiation" of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent Differentiation 2001, 68 (4-5) 235-244
39. Kurozumi, K.; Nakamura, K.; Tamiya, T.; Kawano, Y.; Kobune, M.; Hirai, S.; Uchida, H.; Sasaki, K.; Ito, Y.; Kato, K.; Honmou, O.; Houkin, K.; Date, I.; Hamada, H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model Mol. Ther. 2004, 9 (2) 189-197
40. Himes, B. T.; Liu, Y.; Solowska, J. M.; Snyder, E. Y.; Fischer, I.; Tessler, A. Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats J. Neurosci. Res. 2001, 65 (6) 549-564
41. Lu, P.; Jones, L. L.; Tuszynski, M. H. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury Exp. Neurol. 2005, 191 (2) 344-360
42. Carmen, I. H. A death in the laboratory: the politics of the Gelsinger aftermath Mol. Ther. 2001, 3 (4) 425-428
43. Somia, N.; Verma, I. M. Gene therapy: trials and tribulations Nat. Rev. Genet. 2000, 1 (2) 91-99
44. Longo, S. L.; Griffith, C.; Glass, A.; Shillitoe, E. J.; Post, D. E. Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter Cancer Gene Ther. 2011, 18 (2) 123-134
45. Santos, J. L.; Oliveira, H.; Pandita, D.; Rodrigues, J.; Pego, A. P.; Granja, P. L.; Tomas, H. Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells J. Controlled Release 2010, 144 (1) 55-64
46. Arnaiz, E.; Doucede, L. I.; Garcia-Gallego, S.; Urbiola, K.; Gomez, R.; Tros fr Ilarduya, C.; de la Mata, F. J. Synthesis of Cationic Carbosilane Dendrimers via Click Chemistry and Their Use as Effective Carriers for DNA Transfection into Cancerous Cells Mol. Pharmaceutics 2012, 9, 433-447
47. Filion, M. C.; Phillips, N. C. Major limitations in the use of cationic liposomes for DNA delivery Int. J. Pharm. 1998, 162 (1-2) 159-170
48. Shcharbin, D.; Pedziwiatr, E.; Bryszewska, M. How to study dendriplexes I: Characterization J. Controlled Release 2009, 135 (3) 186-197
49. Santos, J. L.; Oramas, E.; Pego, A. P.; Granja, P. L.; Tomas, H. Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors J. Controlled Release 2009, 134 (2) 141-148
50. Santos, J. L.; Pandita, D.; Rodrigues, J.; Pego, A. P.; Granja, P. L.; Balian, G.; Tomas, H. Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells Mol. Pharmaceutics 2010, 7 (3) 763-774
51. Shakhbazau, A.; Shcharbin, D.; Petyovka, N.; Goncharova, N.; Seviaryn, I.; Kosmacheva, S.; Bryszewska, M.; Potapnev, M. Non-virally modified human mesenchymal stem cells produce ciliary neurotrophic factor in biodegradable fibrin-based 3D scaffolds J. Pharm. Sci. 2012, 101 (4) 1546-1554
52. Coppola, V.; Kucera, J.; Palko, M. E.; Martinez-De Velasco, J.; Lyons, W. E.; Fritzsch, B.; Tessarollo, L. Dissection of NT3 functions in vivo by gene replacement strategy Development 2001, 128 (21) 4315-4327
53. Farinas, I.; Jones, K. R.; Tessarollo, L.; Vigers, A. J.; Huang, E.; Kirstein, M.; de Caprona, D. C.; Coppola, V.; Backus, C.; Reichardt, L. F.; Fritzsch, B. Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression J. Neurosci. 2001, 21 (16) 6170-6180
54. Kemp, S. W.; Webb, A. A.; Dhaliwal, S.; Syed, S.; Walsh, S. K.; Midha, R. Dose and duration of nerve growth factor (NGF) administration determine the extent of behavioral recovery following peripheral nerve injury in the rat Exp. Neurol. 2011, 229 (2) 460-470
55. Ronsyn, M. W.; Daans, J.; Spaepen, G.; Chatterjee, S.; Vermeulen, K.; D'Haese, P.; Van Tendeloo, V. F.; Van Marck, E.; Ysebaert, D.; Berneman, Z. N.; Jorens, P. G.; Ponsaerts, P. Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord BMC Biotechnol. 2007, 7, 90-107
56. Kurozumi, K.; Nakamura, K.; Tamiya, T.; Kawano, Y.; Kobune, M.; Hirai, S.; Uchida, H.; Sasaki, K.; Ito, Y.; Kato, K.; Honmou, O.; Houkin, K.; Date, I.; Hamada, H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model Mol. Ther. 2004, 9 (2) 189-197
57. Gassmann, K.; Abel, J.; Bothe, H.; Haarmann-Stemmann, T.; Merk, H. F.; Quasthoff, K. N.; Rockel, T. D.; Schreiber, T.; Fritsche, E. Species-specific differential AhR expression protects human neural progenitor cells against developmental neurotoxicity of PAHs Environ. Health Perspect. 2010, 118 (11) 1571-1577
58. Caminade, A. M.; Turrin, C. O.; Majoral, J. P. Dendrimers and DNA: combinations of two special topologies for nanomaterials and biology Chemistry 2008, 14 (25) 7422-7432
59. Smith, D. K. Dendrimers and the double helix - from DNA binding towards gene therapy Curr. Top. Med. Chem. 2008, 8 (14) 1187-1203
60. Schutz, S.; Sarnow, P. Interaction of viruses with the mammalian RNA interference pathway Virology 2006, 344 (1) 151-157
61. Berkhout, B.; Haasnoot, J. The interplay between virus infection and the cellular RNA interference machinery FEBS Lett. 2006, 580 (12) 2896-2902
62. Hegseth, M. N.; Regoli, F.; Gorbi, S.; Bocchetti, R.; Gabrielsen, G. W.; Camus, L. Lysosomal and lipid-associated parameters in the livers of three species of arctic seabird chicks: species differences and relationships with contaminant levels Mar. Pollut. Bull. 2011, 62 (8) 1652-1660
63. Keilhoff, G.; Stang, F.; Goihl, A.; Wolf, G.; Fansa, H. Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination Cell Mol. Neurobiol. 2006, 26 (7-8) 1235-1252
64. McKenzie, I. A.; Biernaskie, J.; Toma, J. G.; Midha, R.; Miller, F. D. Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system J. Neurosci. 2006, 26 (24) 6651-6660
65. Biernaskie, J.; Sparling, J. S.; Liu, J.; Shannon, C. P.; Plemel, J. R.; Xie, Y.; Miller, F. D.; Tetzlaff, W. Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury J. Neurosci. 2007, 27 (36) 9545-9559